
Aventusoft is a privately held company founded in 2010, based in Boca Raton, FL, specializing in signal detection analysis within the healthcare industry. They are focused on solving complex healthcare problems, particularly in cardiac health and clinical research, by leveraging AI and digital health platforms. Their key products include Hemotag, an AI platform for cardiac imaging and devices; CarePear, an AI health platform connecting patients and physicians with US-based sub-specialists; and Trialogy, an AI-driven platform for decentralized clinical trials in life sciences. The company has achieved significant growth, ranking 112th on Inc. Magazine's list of the Southeast Region's fastest-growing private companies with a two-year revenue growth of 146%. Aventusoft aims to make high-value clinical assessment accessible and affordable, advancing structural heart health monitoring through innovative technology.

Aventusoft is a privately held company founded in 2010, based in Boca Raton, FL, specializing in signal detection analysis within the healthcare industry. They are focused on solving complex healthcare problems, particularly in cardiac health and clinical research, by leveraging AI and digital health platforms. Their key products include Hemotag, an AI platform for cardiac imaging and devices; CarePear, an AI health platform connecting patients and physicians with US-based sub-specialists; and Trialogy, an AI-driven platform for decentralized clinical trials in life sciences. The company has achieved significant growth, ranking 112th on Inc. Magazine's list of the Southeast Region's fastest-growing private companies with a two-year revenue growth of 146%. Aventusoft aims to make high-value clinical assessment accessible and affordable, advancing structural heart health monitoring through innovative technology.
Location: Boca Raton, Florida
Focus: AI and signal-processing solutions for cardiac/physiological health and clinical research
Founding (conflicting records): Founded dates reported as 2007, 2010, and 2014
Team size: Reported 1–14 employees across sources
Funding type: Government grants (NIH, NSF)
Cardiac/physiological signal detection, clinical research, and digital health
Healthcare / Digital Health
20000
Selection into NIH RADx Tech for Maternal Health Challenge — Viability Assessment Phase award
“Received grant funding from U.S. government agencies including the National Science Foundation and the National Institutes of Health”